2023
DOI: 10.1007/s00417-023-06052-x
|View full text |Cite
|
Sign up to set email alerts
|

Artificial intelligence in retinal disease: clinical application, challenges, and future directions

Abstract: Retinal diseases are a leading cause of blindness in developed countries, accounting for the largest share of visually impaired children, working-age adults (inherited retinal disease), and elderly individuals (age-related macular degeneration). These conditions need specialised clinicians to interpret multimodal retinal imaging, with diagnosis and intervention potentially delayed. With an increasing and ageing population, this is becoming a global health priority. One solution is the development of artificial… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(7 citation statements)
references
References 149 publications
0
7
0
Order By: Relevance
“…Furthermore, AI systems are only as good as the data used to train them. If the data used to train the AI system does not adequately represent the diversity of the population, then the AI system will produce biased outcomes [ 1 , 44 , 45 ]. For example, if the data used to train the AI system comes predominantly from Caucasian patients, then the AI system may be less accurate in detecting eye diseases in other ethnicities.…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, AI systems are only as good as the data used to train them. If the data used to train the AI system does not adequately represent the diversity of the population, then the AI system will produce biased outcomes [ 1 , 44 , 45 ]. For example, if the data used to train the AI system comes predominantly from Caucasian patients, then the AI system may be less accurate in detecting eye diseases in other ethnicities.…”
Section: Resultsmentioning
confidence: 99%
“…These figures are of the same order of magnitude as those that allowed FDA approval of an AI algorithm aimed at diagnosing diabetic retinopathy (IDx-DR: specificity of 87.2% and sensitivity of 90.7%). [19][20][21] This suggests that our AI model may similarly be of value to the health care systems. In terms of grading vitritis into one of the six SUN grades (objective 2), the model showed limited performances (global accuracy of 0.61) in keeping with the low number of images representing the highest grades of vitritis (especially grade 3+ [N = 94] and grade 4+ [N = 59+]).…”
Section: Objective 4: Validation Studymentioning
confidence: 91%
“…The 649 images representing patients with vitritis was a fairly high number when we compare this study with the existing literature on other rare diseases. 19 In fact, unlike diabetic retinopathy, uveitis is a rare disease, and it is fairly impossible to gather millions of images. Increasing this number would therefore need an international and lengthy multicentric effort that we are currently trying to put together.…”
Section: Objective 4: Validation Studymentioning
confidence: 99%
“…The development and validation of AI-powered retinal diseases prioritization tools illustrate this trend. These tools are assessed through rigorous metrics including accuracy, sensitivity, specificity, and area under the curve (AUC), underscoring the precision and reliability of AI in ophthalmology [ 39 ].…”
Section: Deep Learning Techniquesmentioning
confidence: 99%